# Axogen, Inc. (AXGN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Axogen, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AXGN/mda/fy2025/): filed 2026-02-24; accession 0000805928-26-000031 (https://www.sec.gov/Archives/edgar/data/805928/000080592826000031/axgn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AXGN/mda/fy2024/): filed 2025-02-26; accession 0000805928-25-000017 (https://www.sec.gov/Archives/edgar/data/805928/000080592825000017/axgn-20241231.htm)
- [FY 2023 MD&A](/company/AXGN/mda/fy2023/): filed 2024-03-05; accession 0000805928-24-000028 (https://www.sec.gov/Archives/edgar/data/805928/000080592824000028/axgn-20231231.htm)
- [FY 2022 MD&A](/company/AXGN/mda/fy2022/): filed 2023-03-14; accession 0000805928-23-000020 (https://www.sec.gov/Archives/edgar/data/805928/000080592823000020/axgn-20221231.htm)
- [FY 2021 MD&A](/company/AXGN/mda/fy2021/): filed 2022-02-25; accession 0000805928-22-000026 (https://www.sec.gov/Archives/edgar/data/805928/000080592822000026/axgn-20211231.htm)

Back to /company/AXGN/